Importantly, activators of c-MET are secreted by adipose-derived mesenchymal stem cells, which exacerbate oncogenic behaviour of c-Met-expressing breast cancer cells, creating an inflammatory microenvironment, thus increasing tumor growth and angiogenesis. The gene discussed is MET; the disease is breast cancer.